Market Closed -
OTC Markets
01:10:00 06/12/2023 GMT
|
5-day change
|
1st Jan Change
|
7.51
USD
|
-.--%
|
|
-.--%
|
-.--%
|
Fiscal Period: December |
2024
|
2025
|
2026
|
---|
Capitalization
1 |
1,672
|
-
|
-
|
Enterprise Value (EV)
1 |
3,558
|
3,514
|
3,509
|
P/E ratio
|
-483
x
|
152
x
|
-
|
Yield
|
6.91%
|
6.99%
|
6.91%
|
Capitalization / Revenue
|
0.82
x
|
0.78
x
|
0.68
x
|
EV / Revenue
|
1.75
x
|
1.64
x
|
1.42
x
|
EV / EBITDA
|
11.5
x
|
10.6
x
|
10
x
|
EV / FCF
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
Price to Book
|
1.03
x
|
1.1
x
|
1.16
x
|
Nbr of stocks (in thousands)
|
131,647
|
-
|
-
|
Reference price
2 |
14.48
|
14.48
|
14.48
|
Announcement Date
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
1,867
|
2,033
|
2,147
|
2,467
|
EBITDA
1 |
-
|
-
|
308.2
|
330.2
|
349.9
|
EBIT
1 |
-
|
70.92
|
126
|
149.8
|
163.3
|
Operating Margin
|
-
|
3.8%
|
6.2%
|
6.98%
|
6.62%
|
Earnings before Tax (EBT)
|
-
|
-76.22
|
-
|
-
|
-
|
Net income
1 |
-81.3
|
-71.47
|
1.274
|
23.39
|
45.4
|
Net margin
|
-
|
-3.83%
|
0.06%
|
1.09%
|
1.84%
|
EPS
2 |
-1.240
|
-1.080
|
-0.0300
|
0.0950
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
1.000
|
1.012
|
1.000
|
Announcement Date
|
17/03/23
|
21/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
482.6
|
499.5
|
505.9
|
511.3
|
516.9
|
525.9
|
530.6
|
EBITDA
1 |
-
|
74.24
|
74.02
|
75.79
|
80.09
|
82.03
|
77.28
|
EBIT
1 |
25.66
|
24.8
|
30.08
|
32.59
|
37.05
|
38.7
|
34.3
|
Operating Margin
|
5.32%
|
4.96%
|
5.95%
|
6.37%
|
7.17%
|
7.36%
|
6.46%
|
Earnings before Tax (EBT)
|
-31.07
|
-2.726
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-27.42
|
-3.892
|
-0.025
|
0.5415
|
4.703
|
7.285
|
5.396
|
Net margin
|
-5.68%
|
-0.78%
|
-0%
|
0.11%
|
0.91%
|
1.39%
|
1.02%
|
EPS
2 |
-0.4100
|
-0.0400
|
-0.0150
|
-
|
0.0150
|
0.0300
|
0.0400
|
Dividend per Share
2 |
-
|
-
|
0.2500
|
0.2500
|
0.2500
|
0.2500
|
0.2500
|
Announcement Date
|
21/03/24
|
13/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
1,886
|
1,842
|
1,837
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
6.121
x
|
5.579
x
|
5.25
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
0.18%
|
1.36%
|
2.65%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
14.10
|
13.20
|
12.50
|
Cash Flow per Share
2 |
-
|
-
|
1.260
|
1.390
|
-
|
Capex
1 |
-
|
-
|
32
|
32.2
|
33.4
|
Capex / Sales
|
-
|
-
|
1.57%
|
1.5%
|
1.35%
|
Announcement Date
|
17/03/23
|
21/03/24
|
-
|
-
|
-
|
Last Close Price
14.48
USD Average target price
15.88
USD Spread / Average Target +9.63% Consensus |
1st Jan change
|
Capi.
|
---|
| +15.61% | 61.79B | | +2.85% | 20.53B | | +11.71% | 8.33B | | -3.48% | 6.3B | | +12.15% | 3.6B | | +7.92% | 3.5B | | +21.27% | 2.93B | | -11.00% | 2.89B | | -12.22% | 2.8B |
Healthcare REITs
|